Back to search

Article

PRMT3-mediated arginine methylation of YBX1 promotes tumorigenesis in glioblastoma

2026-02-27

Abstract excerpt

<title>Abstract</title> <p> Glioblastoma (GBM) represents one of the most challenging tumor types to treat clinically, characterized by an exceedingly poor patient prognosis. This is primarily attributable to the ambiguous molecular mechanisms that hinder the advancement of targeted therapies. Here, PRMT3 is identified as a key driver of tumorigenesis in GBM. Bioinformatics and clinical data reveal that high exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b6d55c0-a457-5689-b1d9-d07f62ffe87a
DOI
10.21203/rs.3.rs-8924648/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PRMT3-mediated arginine methylation of YBX1 promotes tumorigenesis in glioblastomaDOI 10.21203/rs.3.rs-8924648/v1
Select a neighboring publication to make it the new centre.